These findings underline the essential impact of the tumor-promoting inflammation factor TNF-β as a dominant agent in promoting and supporting EMT and development of CSCs, thus, cancer progression and metastasis in CRC. The gene discussed is LTA; the disease is colorectal carcinoma.